Clinical trial
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered…
NCT00262002 · Novartis Vaccines, Industry · Completed
Key facts
| NCT number | NCT00262002 |
|---|---|
| Title | Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants |
| Official title | A Phase II, Randomized, Open Label, Controlled, Multicenter Study to Evaluate the Safety, Immunogenicity and Induction of Immunological Memory After Two or Three Doses of Novartis (Formerly Chiron) Meningococcal ACWY Conjugate Vaccine Administered to Healthy Infants at 2, 3, 4 or 2, 4, 6 Months of… |
| Lead sponsor | Novartis Vaccines, Industry |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prevention of Meningococcal Disease |
| Intervention type | Biological |
| Interventions | MenACWY Ad- (MenACWY-CRM, non adjuvanted formulation), MenACWY Ad+ (MenACWY-CRM, adjuvanted formulation), MenACWY PS (MenACWY-CRM, polysaccharide vaccine), HBV (Hepatitis B vaccine), Prevnar (pneumococcal polysaccharide serotypes 4, 9V, 14 and 11 more |
| Enrollment | 601 |
| Start date | Sep 1, 2004 |
| Primary completion | Jul 1, 2005 |
| Completion | Oct 1, 2006 |
| First posted | Dec 6, 2005 |
| Last update posted | Jun 18, 2014 |
| Countries | Canada, United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: